JANTZ DEREK 4
4 · PRECISION BIOSCIENCES INC · Filed May 14, 2021
Insider Transaction Report
Form 4
JANTZ DEREK
DirectorChief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-12$0.04/sh+21,514$861→ 4,038,273 total - Exercise/Conversion
Common Stock
2021-05-13$0.04/sh+21,514$861→ 4,050,111 total - Sale
Common Stock
2021-05-12$8.72/sh−9,676$84,375→ 4,028,597 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-05-12−21,514→ 43,028 totalExercise: $0.04Exp: 2021-05-17→ Common Stock (21,514 underlying) - Sale
Common Stock
2021-05-13$9.15/sh−9,673$88,508→ 4,040,438 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-05-13−21,514→ 21,514 totalExercise: $0.04Exp: 2021-05-17→ Common Stock (21,514 underlying)
Footnotes (2)
- [F1]All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
- [F2]The option is fully vested and exercisable.